Abstract
The pharmaceutical valsartan is classified as a trace organic compound and is released into wastewater from human consumption. Trace organic compounds are not completely removed during conventional wastewater treatment. In order to prevent their release into the aquatic environment, advanced wastewater treatment technologies such as ozonation are currently implemented. Ozonation leads to the formation of transformation products (TPs), which then enter the receiving waters. In the present work, laboratory-scale ozonation experiments of valsartan solutions were performed. The resulting TPs were analyzed by HPLC-MS and searched for using a non-targeted approach. Of the 51 compounds detected, 27 have tentative structural suggestions based on MS/MS experiments. Ozonation of valsartan does not lead to the formation of TPs with higher toxicity towards A. fischeri than the parent compound. According to QSAR-based environmental behavior estimations, most TPs reveal lower lipophilicity, increased biodegradability as well as decreased acute and chronic toxicities concerning fish, daphnia and algae compared to their parent compound valsartan.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
